HNRNPA2B1 and breast carcinoma: HnRNPA2/B1 knockdown reduced the resistance of breast cancer cell lines to the chemotherapeutic drug tamoxifen by diminishing the expression of estrogen receptor ERα and phosphorylated Akt, thereby leading to cell death [141].